Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rendu

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Thrombosis and Haemostasis|August 1, 1997
Plasma levels of soluble Fc gamma receptors II (sCD32) and III (sCD16) in patients with heparin-induced thrombocytopeniaR Saffroy, C Bachelot-Loza, W H Fridman, et al.
British Journal of Haematology|January 31, 1998
Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismD Lasne, M Krenn, V Pingault, et al.
Bulletin De L'Academie Nationale De Medecine|October 1, 1991
[Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin]J P Caen, E M Cramer, F Rendu, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
Molecular membrane organization in normal and pathological platelets: changes in inositide metabolism and membrane fluidityF Rendu, P Marche, J Viret, et al.
Series Haematologica (1968)|January 1, 1973
Adenosine metabolism in platelets and plasmaJ P Caen, C S Jenkins, H Michel, et al.
American Journal of Hematology|June 1, 1987
Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylationsF Rendu, J Maclouf, J M Launay, et al.
Biochimie|April 1, 1987
Signal transduction in normal and pathological thrombin-stimulated human plateletsF Rendu, P Marche, J Viret, et al.
Biochemical and Biophysical Research Communications|August 14, 1987
Mechanisms of the mAb ALB6(CD9) induced human platelet activation: comparison with thrombinF Rendu, C Boucheix, M Lebret, et al.
Biochemical Pharmacology|September 1, 1992
Inhibition of platelet activation by tyrosine kinase inhibitorsF Rendu, A Eldor, F Grelac, et al.
British Journal of Haematology|June 1, 1997
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeD Lasne, R Saffroy, C Bachelot, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Thrombosis and Haemostasis|August 1, 1997
Plasma levels of soluble Fc gamma receptors II (sCD32) and III (sCD16) in patients with heparin-induced thrombocytopeniaR Saffroy, C Bachelot-Loza, W H Fridman, et al.
British Journal of Haematology|January 31, 1998
Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphismD Lasne, M Krenn, V Pingault, et al.
Bulletin De L'Academie Nationale De Medecine|October 1, 1991
[Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin]J P Caen, E M Cramer, F Rendu, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
Molecular membrane organization in normal and pathological platelets: changes in inositide metabolism and membrane fluidityF Rendu, P Marche, J Viret, et al.
Series Haematologica (1968)|January 1, 1973
Adenosine metabolism in platelets and plasmaJ P Caen, C S Jenkins, H Michel, et al.
American Journal of Hematology|June 1, 1987
Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylationsF Rendu, J Maclouf, J M Launay, et al.
Biochimie|April 1, 1987
Signal transduction in normal and pathological thrombin-stimulated human plateletsF Rendu, P Marche, J Viret, et al.
Biochemical and Biophysical Research Communications|August 14, 1987
Mechanisms of the mAb ALB6(CD9) induced human platelet activation: comparison with thrombinF Rendu, C Boucheix, M Lebret, et al.
Biochemical Pharmacology|September 1, 1992
Inhibition of platelet activation by tyrosine kinase inhibitorsF Rendu, A Eldor, F Grelac, et al.
British Journal of Haematology|June 1, 1997
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeD Lasne, R Saffroy, C Bachelot, et al.
Pageof 10